AbbVie’s glioblastoma multiforme therapy gets orphan drug status in US and Europe
Every year in the US and Europe, two to three out of every 100,000 people are diagnosed with glioblastoma multiforme, which has a five year survival rate of
Every year in the US and Europe, two to three out of every 100,000 people are diagnosed with glioblastoma multiforme, which has a five year survival rate of
The FDA approval expands the company’s Flexbumin product portfolio to include both 5% in a 250mL solution and 25% in 50 and 100mL solutions. Flexbumin is the first
In December 2013, Apricus expanded its exclusive license agreement with Hexal, an affiliate within Sandoz, for the commercialization of Vitaros in Austria, Belgium, Denmark, Finland, Iceland, Luxemburg, the
The new jointly-owned enterprise will work with researchers at the US university research institutions to identify discoveries that have therapeutic and commercial potential. Allied-Bristol Life Sciences will also
As part of the deal, Roche will make an upfront cash payment of $250m to Santaris shareholders and make additional contingent payments of up to $200m based on
The deal provides toxicity and efficacy studies of cannabinoid formulations carried out in animal models for neurobehavioral diseases including sleep disorders. The company said that the first formulation
In the trial, dosing of the first infant will be carried out within the next few weeks, when Isis will receive an $18m milestone payment from its development
Striverdi Respimat, a long-acting beta agonist (LABA) delivered via a propellant-free inhaler, is not indicated for the treatment of acute deteriorations of COPD and also for asthma. The
Additionally, ANI acquired approved ANDAs from Shire for the currently non-marketed products vancomycin hydrochloride injectable 500mg, 1gm and 10gm and vancomycin hydrochloride oral solution 250mg and 500mg. In
A rare, debilitating neurologic disorder, MG is caused by uncontrolled complement activation due to antibodies directed at the neuromuscular junction, ultimately leading to profound and debilitating weakness of